UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 18, 2015

 

VERACYTE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-36156

 

20-5455398

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

7000 Shoreline Court, Suite 250, South San Francisco, California

 

94080

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (650) 243-6300

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07               Submission of Matters to a Vote of Security Holders.

 

The following actions were taken at the Annual Meeting of Stockholders of Veracyte, Inc., held on May 18, 2015:

 

1.                                      The following Class II Directors were elected to serve until the 2018 Annual Meeting of Stockholders or until their successors are duly elected and qualified:

 

 

 

For

 

Withheld

 

 

 

 

 

 

 

John L. Bishop

 

16,912,634

 

1,944,688

 

 

 

 

 

 

 

Fred E. Cohen

 

16,366,611

 

2,490,711

 

 

There were 1,519,528 broker non-votes for this proposal.

 

2.                                      The vote on the approval of the Veracyte, Inc. Employee Stock Purchase Plan was approved:

 

For

 

Against

 

Abstain

 

 

 

 

 

 

 

18,836,325

 

16,956

 

4,041

 

 

There were 1,519,528 broker non-votes for this proposal.

 

3.                                      The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2015 was approved:

 

For

 

Against

 

Abstain

 

 

 

 

 

 

 

20,365,071

 

10,397

 

1,382

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: May 19, 2015

 

 

 

 

Veracyte, Inc.

 

 

 

 

 

By

/s/ Shelly D. Guyer

 

Name:

Shelly D. Guyer

 

Title:

Chief Financial Officer

 

3